Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Lia DeGroot
ldegroot@endpointsnews.com
author articles
Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says
Last year
Pharma
FDA+
House passes sweeping healthcare price transparency reforms, reining in PBM practices
Last year
Pharma
FDA+
FDA establishes new advisory committee for genetic metabolic disease treatments
Last year
Pharma
FDA+
Bipartisan House bill seeks to boost pediatric drug development via new FDA penalties for noncompliance
Last year
R&D
Pharma
Gavi announces $1.8B for vaccine access, pandemic preparedness efforts in Africa
Last year
R&D
Pharma
House committee advances key PBM bills in step with Senate counterparts
Last year
Pharma
FDA+
Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint
Last year
Pharma
FDA+
The politics behind drug shortages: Senators talk issues with generics market, CMS payments
Last year
Pharma
FDA+
House committee investigates FDA’s handling of common nasal decongestant as efficacy questions loom
Last year
Pharma
FDA+
Improper Orange Book listings harm competition, FTC says in amicus brief to antitrust suit
Last year
Pharma
FDA+
Bernie Sanders invites CEOs of J&J, Merck, Bristol Myers to testify on drug pricing
Last year
People
Pharma
Senate Democrats press AstraZeneca, Sanofi on RSV antibody shortage
Last year
Pharma
FDA+
Pfizer, Astellas clinch expanded approval for Xtandi in earlier line of prostate cancer
Last year
R&D
Pharma
Biden taps Vanderbilt’s Kimryn Rathmell to succeed Bertagnolli as the NIH's cancer chief
Last year
People
Pharma
Merck notches 38th approval for Keytruda, seventh indication for gastrointestinal cancer
Last year
Pharma
FDA+
Slew of House Democrats urge FDA, HHS to preserve access to misoprostol, methotrexate
Last year
Pharma
FDA+
Can post-market evidence generation be streamlined? FDA-commissioned report proposes solutions
Last year
Pharma
FDA+
New NIH chief stresses focus on obesity, clinical trial challenges
Last year
Pharma
FDA+
FDA explains why it denied about 60% of non-oncology breakthrough therapy requests from 2017 to 2019
Last year
Pharma
FDA+
House Republicans threaten to subpoena FDA over Covid research documents
Last year
Pharma
FDA+
ADF asks SCOTUS not to take up mifepristone case as Danco, DOJ say arguments don't hold up
Last year
Pharma
FDA+
Senate Finance Committee unanimously advances PBM, Medicare Part D reforms
Last year
Pharma
FDA+
Senate confirms Monica Bertagnolli to lead NIH with bipartisan 62-36 vote
Last year
Pharma
FDA+
'Pull every lever': Marks doubles down on urgency to improve gene therapy manufacturing
Last year
Pharma
Cell/Gene Tx
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page
